AU6926101A - Method of making particles for use in a pharmaceutical composition - Google Patents

Method of making particles for use in a pharmaceutical composition

Info

Publication number
AU6926101A
AU6926101A AU6926101A AU6926101A AU6926101A AU 6926101 A AU6926101 A AU 6926101A AU 6926101 A AU6926101 A AU 6926101A AU 6926101 A AU6926101 A AU 6926101A AU 6926101 A AU6926101 A AU 6926101A
Authority
AU
Australia
Prior art keywords
pharmaceutical composition
making particles
particles
making
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU6926101A
Inventor
John Nicholas Staniforth
David Alexander Vodden Morton
Rosella Musa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vectura Ltd
Original Assignee
Vectura Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0029263A external-priority patent/GB0029263D0/en
Priority claimed from PCT/GB2001/001732 external-priority patent/WO2001078694A2/en
Application filed by Vectura Ltd filed Critical Vectura Ltd
Priority claimed from PCT/GB2001/002860 external-priority patent/WO2002000197A1/en
Publication of AU6926101A publication Critical patent/AU6926101A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Otolaryngology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU6926101A 2000-06-27 2001-06-27 Method of making particles for use in a pharmaceutical composition Pending AU6926101A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP00113608 2000-06-27
GB0029263A GB0029263D0 (en) 2000-11-30 2000-11-30 Method of making particles for use in a pharmaceutical composition
PCT/GB2001/001732 WO2001078694A2 (en) 2000-04-17 2001-04-17 Formulations for use in inhaler devices
PCT/GB2001/002860 WO2002000197A1 (en) 2000-06-27 2001-06-27 Method of making particles for use in a pharmaceutical composition

Publications (1)

Publication Number Publication Date
AU6926101A true AU6926101A (en) 2002-01-08

Family

ID=27223055

Family Applications (2)

Application Number Title Priority Date Filing Date
AU6926101A Pending AU6926101A (en) 2000-06-27 2001-06-27 Method of making particles for use in a pharmaceutical composition
AU2001269261A Expired AU2001269261B2 (en) 2000-06-27 2001-06-27 Method of making particles for use in a pharmaceutical composition

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2001269261A Expired AU2001269261B2 (en) 2000-06-27 2001-06-27 Method of making particles for use in a pharmaceutical composition

Country Status (5)

Country Link
JP (1) JP5698423B2 (en)
AU (2) AU6926101A (en)
CA (1) CA2413692C (en)
DE (1) DE60131399T3 (en)
DK (1) DK1296651T3 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1849830B1 (en) * 2005-01-28 2012-02-29 Takeda Pharmaceutical Company Limited Finely divided composition containing poorly water soluble substance
ITMI20051999A1 (en) * 2005-10-21 2007-04-22 Eratech S R L INHALATION FORMULATIONS OF DRUGS IN DRY POWDER FOR ADMINISTRATION AS SUCH OR WITH NEBULIZER AND EQUIPPED WITH HIGH EROGABILITY RESPIRABILITY AND STABILITY
EP2560611B1 (en) * 2010-04-21 2018-01-03 Chiesi Farmaceutici S.p.A. "process for providing particles with reduced electrostatic charges"
CA2869849A1 (en) * 2012-04-13 2013-10-17 Glaxosmithkline Intellectual Property Development Limited Aggregate particles comprising nanoparticulate drug particles of umeclidinium bromide, vilanterol trifenatate and fluticasone furoate
PL3019153T3 (en) * 2013-07-11 2019-02-28 Chiesi Farmaceutici S.P.A. Dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic for administration by inhalation
MA40910A (en) * 2014-11-07 2017-09-12 Civitas Therapeutics Inc RAPAMYCIN POWDERS FOR PULMONARY ADMINISTRATION
JPWO2019009335A1 (en) * 2017-07-04 2020-07-02 村上　正裕 Method for producing fine particles and fine particles

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1204826B (en) * 1986-03-04 1989-03-10 Chiesi Farma Spa INHALATION PHARMACEUTICAL COMPOSITIONS
SE8603812D0 (en) * 1986-09-12 1986-09-12 Draco Ab ADMINISTRATION OF LIPOSOMES TO MAMMALS
DE3917617A1 (en) * 1989-05-31 1990-12-06 Boehringer Ingelheim Kg MICRONIZED BIODEGRADABLE PARTICLES, PROCESS FOR THEIR PREPARATION AND THEIR USE
GB2269992A (en) * 1992-08-14 1994-03-02 Rh Ne Poulenc Rorer Limited Powder inhalation formulations
GB9501841D0 (en) * 1995-01-31 1995-03-22 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
GB9515182D0 (en) * 1995-07-24 1995-09-20 Co Ordinated Drug Dev Improvements in and relating to powders for use in dry powder inhalers
ATE287257T1 (en) * 1997-01-16 2005-02-15 Massachusetts Inst Technology PREPARATION OF PARTICLE-CONTAINING MEDICINAL PRODUCTS FOR INHALATION
RU2214244C9 (en) * 1998-03-26 2020-07-29 Астеллас Фарма Инк. Sustained-release preparations
CA2347856C (en) * 1998-11-13 2009-02-17 Jago Research Ag Dry powder for inhalation
GB9826783D0 (en) * 1998-12-04 1999-01-27 Scherer Ltd R P Inhalation powders
GB9827145D0 (en) * 1998-12-09 1999-02-03 Co Ordinated Drug Dev Improvements in or relating to powders

Also Published As

Publication number Publication date
JP2004501183A (en) 2004-01-15
AU2001269261B2 (en) 2005-11-17
CA2413692A1 (en) 2002-01-03
JP5698423B2 (en) 2015-04-08
CA2413692C (en) 2011-10-18
DK1296651T3 (en) 2008-02-11
DE60131399D1 (en) 2007-12-27
DE60131399T3 (en) 2019-11-14
DE60131399T2 (en) 2008-04-17

Similar Documents

Publication Publication Date Title
AU2211502A (en) Method of making particles for use in a pharmaceutical composition
IL153282A0 (en) Method for preparing a pharmaceutical composition
GB2387709B (en) Method for utilizing oral movement and related events
EG24357A (en) New Pharmaceutical composition
EP1341864A4 (en) Method for making abrasive compositions and products thereof
HUP0302499A3 (en) Pharmaceutical compositions of estrogen-cyclodextrin complexes and process for their preparation
AU7801601A (en) Cleaning composition and methods for manufacturing and using
PL360026A1 (en) Methods and composition for oral vaccination
HUP0302130A3 (en) Combination pharmaceutical compositions and process for their preparation
HUP0300539A3 (en) New pharmaceutical composition in form of emulsion preconcentrate
HUP0302099A3 (en) Azythromycin in the form of a monohydrate, process for its preparation and pharmaceutical composition containing in the monohydrate form
IL145188A0 (en) Processes for making pharmaceutical oral ecb formulations and compositions
AU6926101A (en) Method of making particles for use in a pharmaceutical composition
IL153487A0 (en) Pharmaceutical compositions and methods for use
HK1047100B (en) New metalloprotease inhibitors, a process for their preparation and pharmaceutical compositions containing them
GB2377888B (en) Sustained release pharmaceutical composition containing glipizide and method for producing same
IL153897A0 (en) Pharmaceutical compositions and methods for use
HU0101222D0 (en) Mannite in powder form and process for producing thereof
GB0030946D0 (en) Method of making particles for use in a pharmaceutical composition
GB0029263D0 (en) Method of making particles for use in a pharmaceutical composition
GB0029261D0 (en) Method of making particles for use in a pharmaceutical composition
IL152827A0 (en) Herbal composition useful for treatment of oral cavity and a method for the local delivery thereof
EP1307180A4 (en) A method of preparing a pharmaceutical composition
AU8711801A (en) Methods and compositions for producing a neurosalutary effect in a subject
AU2001259564A1 (en) Pharmaceutical compositions and methods for use